Literature DB >> 17994587

Elevated serum homocysteine levels in male patients with PTSD.

Joseph Levine1, Igor Timinsky, Tali Vishne, Tzvi Dwolatzky, Susana Roitman, Zeev Kaplan, Moshe Kotler, Ben-Ami Sela, Baruch Spivak.   

Abstract

It has been suggested that an elevated serum or plasma homocysteine level may be a risk factor for neuropsychiatric conditions such as Alzheimer's disease, schizophrenia, and depression. Because depression is closely related to anxiety disorders, and because it has been suggested that stress may be associated with an elevated homocysteine level, we studied whether serum homocysteine levels are elevated in patients with posttraumatic stress disorder (PTSD). Total serum homocysteine levels in 28 male patients with PTSD were compared to those of 223 healthy controls. The effect of PTSD on the serum homocysteine level was significant (F=42.96, P<.0001). In a regression model for the PTSD patients, the duration of PTSD was found to predict serum homocysteine levels (t=2.228, P=.035). Our results suggest that elevated levels of homocysteine in male patients with PTSD may be related to pathophysiological aspects associated with the chronicity of this disorder. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17994587     DOI: 10.1002/da.20400

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  9 in total

1.  Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats.

Authors:  Bárbara Tagliari; Tiago M dos Santos; Aline A Cunha; Daniela D Lima; Débora Delwing; Angela Sitta; Carmem R Vargas; Carla Dalmaz; Angela T S Wyse
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

2.  Postural control in patients after a recent vestibular neuritis with hyperhomocysteinemia.

Authors:  G Raponi; R Teggi; O Gatti; L Giordano; M Bussi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-12-20

Review 3.  Homocysteine levels in schizophrenia and affective disorders-focus on cognition.

Authors:  Ahmed A Moustafa; Doaa H Hewedi; Abeer M Eissa; Dorota Frydecka; Błażej Misiak
Journal:  Front Behav Neurosci       Date:  2014-10-06       Impact factor: 3.558

4.  Roles of 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in early- and late-onset obsessive-compulsive disorder.

Authors:  Metin Caliskan; Seda Orenay-Boyacioglu; Ayse Dondu
Journal:  Indian J Psychiatry       Date:  2019 Mar-Apr       Impact factor: 1.759

5.  Homocysteine as a potential indicator of endothelial dysfunction and cardiovascular risk in female patients with borderline personality disorder.

Authors:  Katharina Kern; Kathrin Sinningen; Luisa Engemann; Clara Maiß; Beatrice Hanusch; Andreas Mügge; Thomas Lücke; Martin Brüne
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2022-01-03

Review 6.  Neurogenic Interventions for Fear Memory via Modulation of the Hippocampal Function and Neural Circuits.

Authors:  Hee Ra Park; Mudan Cai; Eun Jin Yang
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

7.  Up-Converting Nanocrystals Modified With Fluorescent Markers for the Detection of Amino Acids: Preparation, Characterization, and Sensing Performance.

Authors:  YuLang Fei; Kun Wu; Liang Liu
Journal:  Front Chem       Date:  2022-03-21       Impact factor: 5.221

8.  Increased expression of tumor necrosis factor-alpha in the rat hippocampus after acute homocysteine administration.

Authors:  Seong Hee Kim; Kwangsoo Kim; Ji Hyun Ahn; Hee Kyung Chang
Journal:  J Epilepsy Res       Date:  2011-03-30

9.  Vitamin B12, folate, and homocysteine levels in patients with obsessive-compulsive disorder.

Authors:  Nuray Türksoy; Rabia Bilici; Altan Yalçıner; Y Özay Ozdemir; Ibrahim Ornek; Ali Evren Tufan; Ayşe Kara
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-09       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.